. 2015 Jan 11;262(3):752–759. doi: 10.1007/s00415-014-7618-y

Table 4.

Comparison between IVIg and placebo after the first course of administration

	Change from the baseline	Difference (95 % CI)	p values
MMT sum score
IVIg (group A, n = 8)	8.13 ± 9.49	4.99 (−0.64, 10.63)	0.080
Placebo (groups B and C, n = 15)	3.13 ± 3.52	4.99 (−0.64, 10.63)	0.080
Number of muscles with MMT scores of three or less
IVIg (group A, n = 8)	−4.0 ± 5.3	−3.5 (−6.5, −0.4)	0.028
Placebo (groups B and C, n = 15)	−0.5 ± 1.6	−3.5 (−6.5, −0.4)	0.028
Visual analogue scale
IVIg (group A, n = 8)	−5.00 ± 8.62	0.13 (−7.02, 7.28)	0.969
Placebo (groups B and C, n = 15)	−5.13 ± 7.44	0.13 (−7.02, 7.28)	0.969
Modified Barthel index
IVIg (group A, n = 8)	2.4 ± 4.3	0.5 (−4.3, 5.3)	0.827
Placebo (groups B and C, n = 15)	1.9 ± 5.7	0.5 (−4.3, 5.3)	0.827

MMT manual muscle testing, CI confidence interval